Medtronic MiniMed

Medtronic MiniMed

Medtronic MiniMed

About This Case

The Medtronic MiniMed Insulin Pump, a widely used medical device designed to help manage diabetes, has recently been implicated in a significant lawsuit. This legal action stems from reported injuries and complications associated with the device, including hypoglycemia, seizures, and even diabetic coma.

Statistics

The recalled devices may have a broken or missing retainer ring, which is designed to secure the insulin cartridge in place. The FDA has received over 26,000 error reports on this product, resulting in more than 2,000 injuries and at least one reported death.

The recall encompasses over 320,000 Medtronic MiniMed insulin pumps that aid diabetes patients in regulating their blood sugar levels. These devices are crucial for individuals managing diabetes.

Despite being aware of the issues associated with the MiniMed 600 series models, Medtronic proceeded with their claims. As a result, the scrutiny of the company's diabetes products has experienced a delay, and the projected revenue from the 780G has been excluded from the fiscal 2023 forecast.

The recalled devices may have a broken or missing retainer ring, which is designed to secure the insulin cartridge in place. The FDA has received over 26,000 error reports on this product, resulting in more than 2,000 injuries and at least one reported death.

The recall encompasses over 320,000 Medtronic MiniMed insulin pumps that aid diabetes patients in regulating their blood sugar levels. These devices are crucial for individuals managing diabetes.

Despite being aware of the issues associated with the MiniMed 600 series models, Medtronic proceeded with their claims. As a result, the scrutiny of the company's diabetes products has experienced a delay, and the projected revenue from the 780G has been excluded from the fiscal 2023 forecast.

The recalled devices may have a broken or missing retainer ring, which is designed to secure the insulin cartridge in place. The FDA has received over 26,000 error reports on this product, resulting in more than 2,000 injuries and at least one reported death.

The recall encompasses over 320,000 Medtronic MiniMed insulin pumps that aid diabetes patients in regulating their blood sugar levels. These devices are crucial for individuals managing diabetes.

Despite being aware of the issues associated with the MiniMed 600 series models, Medtronic proceeded with their claims. As a result, the scrutiny of the company's diabetes products has experienced a delay, and the projected revenue from the 780G has been excluded from the fiscal 2023 forecast.

Trust A Firm With Over 10 Years Of Experience In Fighting For Others

Common

Questions

Common

Questions

Common

Questions

01

How much does it cost to hire you?

At our firm, you pay nothing upfront. We only charge a fee if we win your case, and we handle all the initial costs associated with preparing and managing your case. Our clients never receive an invoice or bill, ensuring they have access to top-notch representation without any financial burden.

02

Are MiniMed insulin pumps safe?

Some Medtronic MiniMed insulin pumps were discovered to be defective, posing serious risks to users, such as hypoglycemia, seizures, diabetic coma, and even death.

03

Has the MiniMed insulin pumps been recalled?

After receiving 26,421 consumer complaints regarding device malfunction, the FDA has issued a recall for the Medtronic MiniMed insulin pump products. This includes all lots before October 2019 for MiniMed 630G and all lots before August 2019 for MiniMed 670G.

04

What is the MiniMed Insulin Pump?

An infusion set, a thin tube that attaches to your body, delivers insulin via a device. An insulin pump provides continuous rapid-acting insulin, eliminating frequent injections. The FDA recently recalled Medtronic's 600 series of MiniMed insulin pumps due to a missing or broken retainer ring in the reservoir compartment. This ring is crucial for securing the insulin cartridge. Injuries and complications not adequately addressed on the warning label include hypoglycemia, seizures, diabetic coma, and potentially death. As a result, individuals experiencing such injuries are pursuing a MiniMed Insulin Pump lawsuit for justice regarding their diabetes treatment setbacks.

JJJ: Medtronic MiniMed Case Updates

Update on Medtronic's Minimed Insulin Pump Litigation

July 1, 2023
In June 2023, two federal judges dismissed separate lawsuits against Medtronic concerning the failure of their Minimed insulin pumps. The judges claimed the insulin pump lawsuits are preempted, a legal doctrine based on the Supremacy Clause of the U.S. Constitution, which establishes that federal law takes precedence over state laws when there is a conflict between the two.

Get Started With a Free Consultation

Contact Us

OR